Ricardo Azziz
#109,837
Most Influential Person Now
Researcher
Ricardo Azziz's AcademicInfluence.com Rankings
Ricardo Azzizmedical Degrees
Medical
#1461
World Rank
#1801
Historical Rank
Public Health
#190
World Rank
#198
Historical Rank
Epidemiology
#214
World Rank
#228
Historical Rank

Ricardo Azzizphilosophy Degrees
Philosophy
#4578
World Rank
#7152
Historical Rank
Logic
#1989
World Rank
#2878
Historical Rank

Download Badge
Medical Philosophy
Ricardo Azziz's Degrees
- Masters Business Administration University of Alabama at Birmingham
- Masters Public Health University of Alabama at Birmingham
- PhD Epidemiology University of Alabama at Birmingham
Why Is Ricardo Azziz Influential?
(Suggest an Edit or Addition)Ricardo Azziz's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Polycystic ovary syndrome (2016) (2741)
- The prevalence and features of the polycystic ovary syndrome in an unselected population. (2004) (2522)
- Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. (1998) (1774)
- Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. (2006) (1679)
- The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. (2009) (1670)
- Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline. (2010) (1132)
- Position statement: Utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. (2007) (1103)
- Polycystic ovary syndrome: etiology, pathogenesis and diagnosis (2011) (1073)
- Androgen excess in women: experience with over 1000 consecutive patients. (2004) (799)
- Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome. (2006) (661)
- Criteria, prevalence, and phenotypes of polycystic ovary syndrome. (2016) (595)
- Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double blind, placebo-controlled trial. (2001) (589)
- Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome†‡ (2018) (587)
- Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment. (2005) (538)
- Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome (2018) (515)
- Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin. (1999) (478)
- Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health--National Heart, Lung, and Blood Institute sponsored Women's Ischemia Syndrome Evaluation. (2008) (461)
- Health care-related economic burden of the polycystic ovary syndrome during the reproductive life span. (2005) (448)
- Consensus on infertility treatment related to polycystic ovary syndrome (2008) (448)
- Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature. (2006) (434)
- Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus. (2002) (397)
- Prevalence of polycystic ovary syndrome (PCOS) in first-degree relatives of patients with PCOS. (2001) (355)
- Polycystic ovary syndrome. (2014) (332)
- Adenomyosis: current perspectives. (1989) (330)
- Impact of obesity on the risk for polycystic ovary syndrome. (2008) (329)
- Development of a health-related quality-of-life questionnaire (PCOSQ) for women with polycystic ovary syndrome (PCOS). (1998) (303)
- Visually scoring hirsutism. (2010) (287)
- Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations (2015) (286)
- Clinical review 56: Nonclassic adrenal hyperplasia: current concepts. (1994) (265)
- Phenotypic spectrum of polycystic ovary syndrome: clinical and biochemical characterization of the three major clinical subgroups. (2005) (256)
- The evaluation and management of hirsutism. (2003) (248)
- Prevalence of adrenal androgen excess in patients with the polycystic ovary syndrome (PCOS) (2005) (227)
- Screening for 21-hydroxylase-deficient nonclassic adrenal hyperplasia among hyperandrogenic women: a prospective study. (1999) (214)
- miRNA-93 Inhibits GLUT4 and Is Overexpressed in Adipose Tissue of Polycystic Ovary Syndrome Patients and Women With Insulin Resistance (2013) (213)
- Degree of facial and body terminal hair growth in unselected black and white women: toward a populational definition of hirsutism. (2006) (196)
- Effects of race and family history of type 2 diabetes on metabolic status of women with polycystic ovary syndrome. (2005) (195)
- Diagnosis, epidemiology, and genetics of the polycystic ovary syndrome. (2006) (182)
- 21-Hydroxylase-deficient nonclassic adrenal hyperplasia is a progressive disorder: a multicenter study. (2000) (166)
- Adrenal androgen excess in the polycystic ovary syndrome: sensitivity and responsivity of the hypothalamic-pituitary-adrenal axis. (1998) (161)
- Replication of association of DENND1A and THADA variants with polycystic ovary syndrome in European cohorts (2011) (159)
- 21-Hydroxylase deficiency in female hyperandrogenism: screening and diagnosis. (1989) (156)
- Diagnostic criteria for polycystic ovary syndrome: a reappraisal. (2005) (155)
- Reproductive outcome of women with 21-hydroxylase-deficient nonclassic adrenal hyperplasia. (2007) (150)
- Role of diet in the treatment of polycystic ovary syndrome. (2006) (146)
- Use of metformin in polycystic ovary syndrome. (2008) (143)
- Improvement in endothelial structure and function after metformin treatment in young normal-weight women with polycystic ovary syndrome: results of a 6-month study. (2005) (140)
- Measurement of total serum testosterone levels using commercially available kits: high degree of between-kit variability. (1998) (139)
- Health-related quality of life in women with polycystic ovary syndrome, a self-administered questionnaire, was validated. (2004) (137)
- Diagnosis of Polycystic Ovary Syndrome (2007) (137)
- Prevalence of hyperandrogenemia in the polycystic ovary syndrome diagnosed by the National Institutes of Health 1990 criteria. (2010) (137)
- Difference in dietary intake between women with polycystic ovary syndrome and healthy controls. (2006) (134)
- Referral bias in defining the phenotype and prevalence of obesity in polycystic ovary syndrome. (2013) (133)
- Epigenetic Mechanism Underlying the Development of Polycystic Ovary Syndrome (PCOS)-Like Phenotypes in Prenatally Androgenized Rhesus Monkeys (2011) (130)
- CYP11B1 mutations causing non-classic adrenal hyperplasia due to 11 beta-hydroxylase deficiency. (1997) (128)
- Reproductive endocrinologic alterations in female asymptomatic obesity. (1989) (126)
- Effects of aging on adrenal function in the human: responsiveness and sensitivity of adrenal androgens and cortisol to adrenocorticotropin in premenopausal and postmenopausal women. (2000) (124)
- DHEA, DHEAS and PCOS (2015) (122)
- PCOS: a diagnostic challenge. (2004) (120)
- Hyperandrogenemia in patients presenting with acne. (2001) (119)
- Polycystic ovary syndrome: an ancient disorder? (2011) (118)
- Idiopathic hirsutism: an uncommon cause of hirsutism in Alabama. (1998) (117)
- Androgen excess is the key element in polycystic ovary syndrome. (2003) (112)
- Polycystic Ovary Syndrome. (2018) (111)
- The adrenal and polycystic ovary syndrome (2007) (109)
- Microsurgery alone or with INTERCEED Absorbable Adhesion Barrier for pelvic sidewall adhesion re-formation. The INTERCEED (TC7) Adhesion Barrier Study Group II. (1993) (104)
- Non-classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency revisited: an update with a special focus on adolescent and adult women. (2017) (104)
- Diagnosis, phenotype, and prevalence of polycystic ovary syndrome. (2006) (104)
- Epigenetics in polycystic ovary syndrome: a pilot study of global DNA methylation. (2010) (101)
- Elevated interleukin-6 levels in peritoneal fluid of patients with pelvic pathology. (1992) (100)
- Defining hirsutism in Chinese women: a cross-sectional study. (2011) (100)
- Phenotypes and body mass in women with polycystic ovary syndrome identified in referral versus unselected populations: systematic review and meta-analysis. (2016) (97)
- Association of androgen receptor CAG repeat polymorphism and polycystic ovary syndrome. (2008) (97)
- Anti-Müllerian Hormone in PCOS: A Review Informing International Guidelines (2019) (96)
- Exploring the potential association between brominated diphenyl ethers, polychlorinated biphenyls, organochlorine pesticides, perfluorinated compounds, phthalates, and bisphenol a in polycystic ovary syndrome: a case–control study (2014) (94)
- Polycystic ovary syndrome in Mexican-Americans: prevalence and association with the severity of insulin resistance. (2005) (94)
- Nonclassic Congenital Adrenal Hyperplasia (2010) (94)
- Testing and interpreting measures of ovarian reserve: a committee opinion. (2020) (91)
- Total testosterone and DHEAS levels as predictors of androgen-secreting neoplasms: a populational study. (1999) (91)
- The phenotype of hirsute women: a comparison of polycystic ovary syndrome and 21-hydroxylase-deficient nonclassic adrenal hyperplasia. (2010) (90)
- FTO and MC4R Gene Variants Are Associated with Obesity in Polycystic Ovary Syndrome (2011) (89)
- Adrenal androgen excess in hyperandrogenism: relation to age and body mass. (1999) (89)
- DHEA-S levels and cardiovascular disease mortality in postmenopausal women: results from the National Institutes of Health--National Heart, Lung, and Blood Institute (NHLBI)-sponsored Women's Ischemia Syndrome Evaluation (WISE). (2010) (89)
- MicroRNA-223 Expression Is Upregulated in Insulin Resistant Human Adipose Tissue (2015) (88)
- Introduction: Determinants of polycystic ovary syndrome. (2016) (85)
- Impact of FTO genotypes on BMI and weight in polycystic ovary syndrome: a systematic review and meta-analysis (2012) (85)
- Pro-453 to Ser mutation in CYP21 is associated with nonclassic steroid 21-hydroxylase deficiency. (1992) (85)
- Variants in the 5alpha-reductase type 1 and type 2 genes are associated with polycystic ovary syndrome and the severity of hirsutism in affected women. (2006) (84)
- Systems Genetics Reveals the Functional Context of PCOS Loci and Identifies Genetic and Molecular Mechanisms of Disease Heterogeneity (2015) (84)
- Favourable metabolic effects of a eucaloric lower‐carbohydrate diet in women with PCOS (2013) (83)
- Androgen excess: Investigations and management. (2016) (82)
- The prevalence of androgen excess among patients with minimal unwanted hair growth. (2004) (82)
- Troglitazone decreases adrenal androgen levels in women with polycystic ovary syndrome. (2003) (81)
- A multicenter study of women with nonclassical congenital adrenal hyperplasia: relationship between genotype and phenotype. (2000) (80)
- Novel Pathway of Adipogenesis through Cross-Talk between Adipose Tissue Macrophages, Adipose Stem Cells and Adipocytes: Evidence of Cell Plasticity (2011) (80)
- Resistin Stimulation of 17α-Hydroxylase Activity in Ovarian Theca Cells in Vitro: Relevance to Polycystic Ovary Syndrome (2005) (78)
- 11β-Hydroxylase deficiency in hyperandrogenism * † (1991) (77)
- Carriers of 21-hydroxylase deficiency are not at increased risk for hyperandrogenism. (1997) (76)
- Guidelines for the Development of Comprehensive Care Centers for Congenital Adrenal Hyperplasia: Guidance from the CARES Foundation Initiative (2010) (76)
- Androgen excess disorders in women (2007) (76)
- Prevalence of polycystic ovary syndrome in women seeking treatment from community electrologists. Alabama Professional Electrology Association Study Group. (1999) (75)
- Family history as a risk factor for the polycystic ovary syndrome. (2000) (74)
- Stein and Leventhal: 80 years on. (2016) (72)
- Congenital adrenal hyperplasia: long-term results following vaginal reconstruction. (1986) (71)
- Leuprolide and estrogen versus oral contraceptive pills for the treatment of hirsutism: a prospective randomized study. (1995) (69)
- Abnormal expression of genes involved in inflammation, lipid metabolism, and Wnt signaling in the adipose tissue of polycystic ovary syndrome. (2012) (69)
- Prospective Association of Polycystic Ovary Syndrome With Coronary Artery Calcification and Carotid-Intima-Media Thickness: The Coronary Artery Risk Development in Young Adults Women’s Study (2014) (69)
- Laser hair reduction in the hirsute patient: a critical assessment. (2002) (69)
- Adrenocortical hyperresponsiveness to corticotropin in polycystic ovary syndrome patients with adrenal androgen excess. (2004) (67)
- Minimal response of circulating lipids in women with polycystic ovary syndrome to improvement in insulin sensitivity with troglitazone. (2003) (66)
- Degree of hyperinsulinemia, independent of androgen levels, is an important determinant of the severity of hirsutism in PCOS. (2009) (66)
- Adrenal function during childhood and puberty in daughters of women with polycystic ovary syndrome. (2009) (66)
- Socioeconomic and racial predictors of undergoing laparoscopic hysterectomy for selected benign diseases: analysis of 341487 hysterectomies. (2008) (65)
- Idiopathic hirsutism. (2000) (62)
- Cardiovascular Disease and 10-Year Mortality in Postmenopausal Women with Clinical Features of Polycystic Ovary Syndrome. (2016) (62)
- The age-associated decline of androgens in reproductive age and menopausal Black and White women. (2007) (60)
- Further investigation in europeans of susceptibility variants for polycystic ovary syndrome discovered in genome-wide association studies of Chinese individuals. (2015) (60)
- Identification and characterization of cytosolic sulfotransferases in normal human endometrium. (1998) (58)
- PCOS in 2015: New insights into the genetics of polycystic ovary syndrome (2016) (57)
- Genital anomalies in childhood. (1987) (57)
- Laparoscopic surgery for ectopic pregnancies: technology assessment and public health implications. (1993) (57)
- Effects of a eucaloric reduced-carbohydrate diet on body composition and fat distribution in women with PCOS. (2014) (57)
- Adrenal androgen excess in women: lack of a role for 17-hydroxylase and 17,20-lyase dysregulation. (1995) (56)
- The severity of menstrual dysfunction as a predictor of insulin resistance in PCOS. (2013) (56)
- Acute adrenocorticotropin-(1-24) (ACTH) adrenal stimulation in eumenorrheic women: reproducibility and effect of ACTH dose, subject weight, and sampling time. (1990) (52)
- Congenital adrenal hyperplasia. (2011) (51)
- 21-hydroxylase-deficient nonclassic adrenal hyperplasia: the great pretender. (2003) (51)
- A Summary of the Endocrine Society Clinical Practice Guidelines on Congenital Adrenal Hyperplasia due to Steroid 21-Hydroxylase Deficiency (2010) (51)
- Regulation of adiponectin secretion by adipocytes in the polycystic ovary syndrome: role of tumor necrosis factor-{alpha}. (2010) (51)
- 3β-Hydroxysteroid dehydrogenase deficiency in hyperandrogenism (1993) (50)
- Heritability and the risk of developing androgen excess (1999) (49)
- Laparoscopic evaluation following failure to achieve pregnancy after ovulation induction with clomiphene citrate. (2003) (49)
- Polycystic ovary syndrome, insulin resistance, and molecular defects of insulin signaling. (2002) (49)
- Bidirectional Mendelian randomization to explore the causal relationships between body mass index and polycystic ovary syndrome (2018) (48)
- Use of ethinylestradiol/drospirenone combination in patients with the polycystic ovary syndrome (2008) (48)
- Association of fat to lean mass ratio with metabolic dysfunction in women with polycystic ovary syndrome. (2014) (48)
- Genetic variants in peroxisome proliferator-activated receptor gamma influence insulin resistance and testosterone levels in normal women, but not those with polycystic ovary syndrome. (2007) (47)
- Female Pattern Hair Loss and Androgen Excess: A Report From the Multidisciplinary Androgen Excess and PCOS Committee. (2019) (47)
- Replication of association of a novel insulin receptor gene polymorphism with polycystic ovary syndrome. (2011) (47)
- Reanalyzing the modified Ferriman-Gallwey score: is there a simpler method for assessing the extent of hirsutism? (2009) (47)
- Prevalence of CYP21 mutations and IRS1 variant among women with polycystic ovary syndrome and adrenal androgen excess. (2005) (47)
- A pilot randomized, single-blind, placebo-controlled trial of traditional acupuncture for vasomotor symptoms and mechanistic pathways of menopause (2012) (47)
- Chronic hyperinsulinemia and the adrenal androgen response to acute corticotropin-(1-24) stimulation in hyperandrogenic women. (1995) (47)
- Ovulation after glucocorticoid suppression of adrenal androgens in the polycystic ovary syndrome is not predicted by the basal dehydroepiandrosterone sulfate level. (1999) (46)
- Specificity and predictive value of circulating testosterone assessed by tandem mass spectrometry for the diagnosis of polycystic ovary syndrome by the National Institutes of Health 1990 criteria. (2014) (45)
- Glucose action and adrenocortical biosynthesis in women with polycystic ovary syndrome. (2004) (45)
- Genetics of polycystic ovary syndrome (2017) (45)
- The effects of prolonged hypertestosteronemia on adrenocortical biosynthesis in oophorectomized women. (1991) (45)
- Role of the ovary in the adrenal androgen excess of hyperandrogenic women. (1998) (45)
- Socioeconomic status and polycystic ovary syndrome. (2011) (44)
- Promoting Residents' Professional Development and Academic Productivity Using a Structured Faculty Mentoring Program (2010) (43)
- The Development of the Polycystic Ovary Syndrome: Family History as a Risk Factor (1998) (43)
- Influence of insulin and testosterone on adrenocortical steroidogenesis in vitro: preliminary studies. (2001) (43)
- Adenomyosis in pregnancy. A review. (1986) (42)
- PCOS in 2015: New insights into the genetics of polycystic ovary syndrome (2016) (42)
- Practical Manual of Operative Laparoscopy and Hysteroscopy (1997) (40)
- From the eye of the nurses: 360‐degree evaluation of residents (2009) (40)
- The Effect of 17β-Estradiol on Adrenocortical Sensitivity, Responsiveness, and Steroidogenesis in Postmenopausal Women1 (1998) (39)
- Role of a CYP17 polymorphism in the regulation of circulating dehydroepiandrosterone sulfate levels in women with polycystic ovary syndrome. (2004) (39)
- Perspectives on Polycystic Ovary Syndrome: Is Polycystic Ovary Syndrome Research Underfunded? (2017) (38)
- Adrenocortical secretion of dehydroepiandrosterone in healthy women: highly variable response to adrenocorticotropin. (2001) (38)
- Dehydroepiandrosterone sulfate and insulin resistance in patients with polycystic ovary syndrome. (2009) (38)
- Association study of four key folliculogenesis genes in polycystic ovary syndrome (2010) (37)
- Total estrogen time and obstructive coronary disease in women: insights from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE). (2009) (36)
- Repeated freezing and thawing does not generally alter assay results for several commonly studied reproductive hormones. (2001) (36)
- Polycystic Ovary Syndrome Is Associated with an Increased Prevalence of Irritable Bowel Syndrome (2010) (36)
- The role of the adrenal cortex in polycystic ovary syndrome. (2001) (36)
- On the origin of the elevated 17-hydroxyprogesterone levels after adrenal stimulation in hyperandrogenism. (1990) (36)
- The development and use of a standard symphysial‐fundal height growth curve in the prediction of small for gestational age neonates (1988) (35)
- The expression of the miR-25/93/106b family of micro-RNAs in the adipose tissue of women with polycystic ovary syndrome. (2014) (35)
- How prevalent is metabolic syndrome in women with polycystic ovary syndrome? (2006) (35)
- Recommendations for epidemiologic and phenotypic research in polycystic ovary syndrome: an androgen excess and PCOS society resource. (2019) (35)
- Genes for enzymes regulating dehydroepiandrosterone sulfonation are associated with levels of dehydroepiandrosterone sulfate in polycystic ovary syndrome. (2007) (35)
- The time has come to simplify the evaluation of the hirsute patient. (2000) (34)
- FSH Beyond Fertility (2019) (33)
- Complex diseases and co-morbidities: polycystic ovary syndrome and type 2 diabetes mellitus (2019) (33)
- Berberine inhibits the proliferation of human uterine leiomyoma cells. (2015) (32)
- Postoperative recuperation: relation to the extent of endoscopic surgery. (1989) (32)
- First Evidence of Genetic Association Between AKT2 and Polycystic Ovary Syndrome (2008) (32)
- Molecular abnormalities of the 21-hydroxylase gene in hyperandrogenic women with an exaggerated 17-hydroxyprogesterone response to short-term adrenal stimulation. (1995) (32)
- Examination of the chin or lower abdomen only for the prediction of hirsutism. (2000) (32)
- Risks for Gestational Diabetes Mellitus and Pregnancy-Induced Hypertension Are Increased in Polycystic Ovary Syndrome (2013) (32)
- Resistin stimulation of 17alpha-hydroxylase activity in ovarian theca cells in vitro: relevance to polycystic ovary syndrome. (2005) (31)
- Stability of adrenocortical steroidogenesis over time in healthy women and women with polycystic ovary syndrome. (2004) (31)
- Ovarian and adipose tissue dysfunction in polycystic ovary syndrome: report of the 4th special scientific meeting of the Androgen Excess and PCOS Society. (2010) (31)
- Polycystic Ovarian Syndrome: Long-Term Health Consequences (2017) (31)
- The relationship of menopausal status and rapid menopausal transition with carotid intima-media thickness progression in women: a report from the Los Angeles Atherosclerosis Study. (2010) (30)
- Association study of CYP17 and HSD11B1 in polycystic ovary syndrome utilizing comprehensive gene coverage. (2012) (30)
- Type 2 diabetes susceptibility single-nucleotide polymorphisms are not associated with polycystic ovary syndrome. (2011) (30)
- O-16:Fifteen-year trend in the inpatient utilization of female reproductive surgery: Analysis of the nationwide inpatient sample (NIS) of the healthcare cost and utilization project (2006) (30)
- Negative association between androgen receptor gene CAG repeat polymorphism and polycystic ovary syndrome? A systematic review and meta-analysis. (2012) (30)
- Evolutionary determinants of polycystic ovary syndrome: part 2. (2016) (29)
- Health Care-Related Economic Burden of Polycystic Ovary Syndrome in the United States: Pregnancy-Related and Long-Term Health Consequences. (2021) (29)
- Heritability of dehydroepiandrosterone sulfate in women with polycystic ovary syndrome and their sisters. (2006) (29)
- Effect of obesity on the response to acute adrenocorticotropin stimulation in eumenorrheic women. (1991) (28)
- Altered autophosphorylation of the insulin receptor in the ovary of a woman with polycystic ovary syndrome. (2001) (28)
- Independent confirmation of association between metabolic phenotypes of polycystic ovary syndrome and variation in the type 6 17beta-hydroxysteroid dehydrogenase gene. (2009) (28)
- Small glutamine-rich tetratricopeptide repeat-containing protein alpha (SGTA), a candidate gene for polycystic ovary syndrome. (2008) (27)
- Relations between endogenous androgens and estrogens in postmenopausal women with suspected ischemic heart disease. (2008) (27)
- The Polycystic Ovary Syndrome: Current Concepts On Pathogenesis And Clinical Care (2007) (27)
- Effects of endogenous androgens and abdominal fat distribution on the interrelationship between insulin and non-insulin-mediated glucose uptake in females. (2013) (27)
- Ovarian hormones and adrenal androgens during a woman's life span. (2001) (27)
- Nonreplication of the type 5 17beta-hydroxysteroid dehydrogenase gene association with polycystic ovary syndrome. (2008) (26)
- Erratum: PCOS in 2015: New insights into the genetics of polycystic ovary syndrome (Nature Reviews Endocrinology (2016) 12 (7475)) DOI:10.1038/nrendo.2015.230) (2016) (26)
- Adrenocortical hyperresponsivity to adrenocorticotropic hormone: a mechanism favoring the normal production of cortisol in 21-hydroxylase-deficient nonclassic adrenal hyperplasia. (2000) (25)
- Dopamine D3 receptor polymorphism is not associated with the polycystic ovary syndrome. (1999) (25)
- Advances in the diagnosis and treatment of the hirsute patient. (1995) (25)
- DHEA-S Levels and Cardiovascular Disease Mortality in Postmenopausal Women: Results From the National Institutes of Health—National Heart, Lung, and Blood Institute (NHLBI)-Sponsored Womenʼs Ischemia Syndrome Evaluation (WISE) (2011) (25)
- Adipocytes from women with polycystic ovary syndrome demonstrate altered phosphorylation and activity of glycogen synthase kinase 3. (2008) (25)
- The treatment of hyperandrogenism with oral contraceptives. (1989) (25)
- Prevalence of 21-hydroxylase-deficient nonclassic adrenal hyperplasia and insulin resistance among hirsute women from Puerto Rico. (2000) (24)
- Association of CYP3A7*1C and serum dehydroepiandrosterone sulfate levels in women with polycystic ovary syndrome. (2008) (24)
- Steroidogenic regulatory factor FOS is underexpressed in polycystic ovary syndrome (PCOS) adipose tissue and genetically associated with PCOS susceptibility. (2012) (23)
- The hyperandrogenic-insulin-resistant acanthosis nigricans syndrome: therapeutic response. (1994) (23)
- FEM1A and FEM1B: novel candidate genes for polycystic ovary syndrome. (2008) (23)
- Polycystic ovary syndrome is a family affair. (2008) (22)
- A variant of the glucocorticoid receptor gene is not associated with adrenal androgen excess in women with polycystic ovary syndrome. (2000) (22)
- Berberine regulates the protein expression of multiple tumorigenesis-related genes in hepatocellular carcinoma cell lines (2017) (21)
- Metabolic and cardiovascular genes in polycystic ovary syndrome: A candidate-wide association study (CWAS) (2012) (21)
- The effect of 17 beta-estradiol on adrenocortical sensitivity, responsiveness, and steroidogenesis in postmenopausal women. (1998) (21)
- Regulation of extragonadal insulin-like growth factor-binding protein-3 by testosterone in oophorectomized women. (1994) (20)
- Adrenal Androgens and Reproductive Aging in Females (1991) (20)
- Essential Reproductive Medicine (2004) (20)
- Minimal difference in phenotype between adolescents and young adults with polycystic ovary syndrome. (2019) (20)
- Prevalence of hyperandrogenemia among nonhirsute oligo-ovulatory women. (1997) (20)
- Polycystic ovary syndrome: what's in a name? (2014) (20)
- Adrenal androgen production in response to adrenocorticotropin infusions in men. (1996) (20)
- Use of an oxidized, regenerated cellulose absorbable adhesion barrier at laparoscopy. (1991) (20)
- Abnormalities of 21-hydroxylase gene ratio and adrenal steroidogenesis in hyperandrogenic women with an exaggerated 17-hydroxyprogesterone response to acute adrenal stimulation. (1991) (20)
- Effect of oral estrogen on substrate utilization in postmenopausal women. (2008) (19)
- Prevalence of 3beta-hydroxysteroid dehydrogenase-deficient nonclassic adrenal hyperplasia in hyperandrogenic women with adrenal androgen excess. (1999) (18)
- Non-classic adrenal hyperplasia in hyperandrogenism: A reappraisal (1998) (18)
- The pressing need for standardization in epidemiologic studies of PCOS across the globe (2019) (18)
- The 21-Hydroxylase-Deficient Adrenal Hyperplasias: More Than ACTH Oversecretion (1996) (18)
- No acute effect of physiological insulin increase on dehydroepiandrosterone sulfate in women with obesity and/or polycystic ovarian disease. (1991) (18)
- Effect of oral micronized progesterone on androgen levels in women with polycystic ovary syndrome. (2002) (18)
- Impact of overnight dexamethasone suppression on the adrenal androgen response to an oral glucose tolerance test in women with and without polycystic ovary syndrome. (1997) (17)
- Preliminary evidence of glycogen synthase kinase 3 beta as a genetic determinant of polycystic ovary syndrome. (2007) (16)
- LEUPROLIDE AND ESTROGEN VERSUS ORAL CONTRACEPTIVE PILLS FOR THE TREATMENT OF HIRSUTISM : A PROSPECTIVE RANDOMIZED STUDY (1996) (16)
- Magnetic resonance imaging of the adrenal gland in women with late-onset adrenal hyperplasia. (1991) (16)
- Correlation of adrenocorticotropin steroid levels between women with polycystic ovary syndrome and their sisters. (2007) (16)
- The Associations Between Residents' Behavior and the Thomas-Kilmann Conflict MODE Instrument. (2010) (16)
- Collaborations , alliances and mergers Mergers in Higher Education : A Proactive Strategy to a Better Future ? (2017) (16)
- 11beta-hydroxyandrostenedione and delta5-androstenediol as markers of adrenal androgen production in patients with 21-hydroxylase-deficient nonclassic adrenal hyperplasia. (1999) (16)
- Steroidogenic acute regulatory protein (StAR) in the ovaries of healthy women and those with polycystic ovary syndrome. (2001) (16)
- Differential binding of estradiol and testosterone to SHBG. Relation to circulating estradiol levels. (1998) (15)
- Peri-muscular adipose tissue may play a unique role in determining insulin sensitivity/resistance in women with polycystic ovary syndrome (2016) (15)
- Identifying and Developing Leadership Competencies in Health Research Organizations: A Pilot Study. (2012) (14)
- Acute myometritis and chorioamnionitis during cesarean section of asymptomatic women. (1988) (14)
- Does the risk of diabetes and heart disease in women with polycystic ovary syndrome lessen with age? (2017) (14)
- Genetic basis of eugonadal and hypogonadal female reproductive disorders. (2017) (13)
- Effect of insulin and testosterone on androgen production and transcription of SULT2A1 in the NCI-H295R adrenocortical cell line. (2009) (13)
- PCOS: Animal models for PCOS — not the real thing (2017) (13)
- Family size in women with polycystic ovary syndrome. (2006) (13)
- Basal metabolic rate in women with PCOS compared to eumenorrheic controls (2015) (13)
- A twenty-first century research agenda for polycystic ovary syndrome. (2006) (13)
- 11 beta-hydroxylase deficiency in hyperandrogenism. (1991) (12)
- Environmental Pollutant Benzo[a]pyrene Induces Recurrent Pregnancy Loss through Promoting Apoptosis and Suppressing Migration of Extravillous Trophoblast (2020) (12)
- Harnessing Expression Data to Identify Novel Candidate Genes in Polycystic Ovary Syndrome (2011) (12)
- Adrenal progestogen and androgen production in 21-hydroxylase-deficient nonclassic adrenal hyperplasia is partially independent of adrenocorticotropic hormone stimulation. (2002) (12)
- Facial and abdominal hair growth in hirsutism: a computerized evaluation. (2001) (12)
- Racial and ethnic differences in the metabolic response of polycystic ovary syndrome (2020) (12)
- Early Adrenarche in Normal Prepubertal Girls: A Prospective Longitudinal Study (2004) (11)
- Association study of androgen signaling pathway genes in polycystic ovary syndrome. (2016) (11)
- Effect of bilateral oophorectomy on adrenocortical function in women with polycystic ovary syndrome. (2013) (11)
- Adipocyte Insulin Resistance In PCOS: Relationship With GLUT-4 Expression, Whole-Body Glucose Disposal, β-Cell Function. (2020) (11)
- Recommendations for reducing the risk of viral transmission during fertility treatment with the use of autologous gametes: a committee opinion. (2020) (11)
- We should avoid the indiscriminate use of insulin sensitizers in women with polycystic ovary syndrome. (2003) (11)
- Definition, Diagnosis, and Epidemiology of the Polycystic Ovary Syndrome (2007) (11)
- Menstrual dysfunction in polycystic ovary syndrome: association with dynamic state insulin resistance rather than hyperandrogenism. (2021) (11)
- Diagnosing the diagnosis: why we must standardize the defining features of polycystic ovary syndrome (2008) (10)
- 21-hydroxylase-deficient nonclassic adrenal hyperplasia (1995) (10)
- Androgen excess disorders (2012) (10)
- FTO and MC 4 R Gene Variants Are Associated with Obesity in Polycystic Ovary Syndrome (2015) (10)
- Comprehensive assessment of expression of insulin signaling pathway components in subcutaneous adipose tissue of women with and without polycystic ovary syndrome (2015) (10)
- Pseudogene/functional gene ratio in late-onset 21-hydroxylase-deficient adrenal hyperplasia. (1990) (10)
- The effectiveness of the interview for predicting the presence of polycystic ovary syndrome (2003) (10)
- Operative endoscopy: the pressing need for a structured training and credentialing process. (1992) (9)
- Impact of architectural disruption on adrenocortical steroidogenesis in vitro. (1999) (9)
- 3 beta-hydroxysteroid dehydrogenase deficiency in hyperandrogenism. (1993) (9)
- Role of reproductive surgeons and the Society of Reproductive Surgeons. (2002) (9)
- Adipocyte expression of glucose transporter 1 and 4 in PCOS: Relationship to insulin‐mediated and non–insulin‐mediated whole‐body glucose uptake (2019) (9)
- Serum complexed and free prostate-specific antigen (PSA) for the diagnosis of the polycystic ovarian syndrome (PCOS) (2017) (9)
- Androgen response to hypothalamic-pituitary-adrenal stimulation with naloxone in women with myotonic muscular dystrophy. (1998) (8)
- ∆5-Androstene-3β,17β-diol in healthy eumenorrheic women: relationship to body mass and hormonal profile * † (1994) (8)
- Variants in the HMG-CoA reductase (HMGCR) gene influence component phenotypes in polycystic ovary syndrome. (2010) (8)
- Corrigendum: Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations (2016) (8)
- Disparities in cardio-metabolic risk between Black and White women with polycystic ovary syndrome: a systematic review and meta-analysis. (2020) (8)
- Advantages and Disadvantages of Operative Endoscopy (1992) (7)
- Long-Term Response of Hirsutism and Other Hyperandrogenic Symptoms to Combination Therapy in Polycystic Ovary Syndrome. (2018) (7)
- Polycystic ovary syndrome and ovulation induction. (2003) (7)
- Natural history of polycystic ovary syndrome: A systematic review of cardiometabolic outcomes from longitudinal cohort studies (2021) (7)
- SCREENING FOR androgen excess IN WOMEN: accuracy of self-reported excess body hair growth and menstrual dysfunction. (2020) (7)
- Training and Certification in Operative Endoscopy (1992) (7)
- Why we need epidemiologic studies of polycystic ovary syndrome in Africa (2018) (7)
- Evaluating professionalism, practice-based learning and improvement, and systems-based practice: utilization of a compliance form and correlation with conflict styles. (2010) (7)
- Clinical Features of the Polycystic Ovary Syndrome (2006) (7)
- Evaluation for Insulin Resistance and Comorbidities Related to Insulin Resistance in Polycystic Ovary Syndrome (2007) (7)
- Differential diagnosis of clinically evident hyperandrogenism: experience with over 1000 consecutive patients. (2001) (7)
- Fifteen‐year trend in the use of male reproductive surgery: analysis of the healthcare cost and utilization project data (2011) (6)
- Overview of Long-Term Morbidity and Economic Cost of the Polycystic Ovary Syndrome (2006) (6)
- Reproductive hormone exposure timing and ischemic heart disease: Complicated answers to a simple question. (2010) (6)
- Berberine Inhibits Uterine Leiomyoma Cell Proliferation via Downregulation of Cyclooxygenase 2 and Pituitary Tumor-Transforming Gene 1 (2017) (6)
- Prevalence of Metabolic Syndrome and Overweight/Obesity amongChinese Women of Childbearing Age: A Cross-Sectional Epidemic Study (2014) (6)
- Small leucine-rich proteoglycans (SLRPs) in the endometrium of polycystic ovary syndrome women: a pilot study (2017) (6)
- Fifteen-year trend in the use of reproductive surgery in women in the United States. (2009) (6)
- Training, Certification, and Credentialing in Gynecologic Operative Endoscopy (1995) (6)
- ANDROGEN EXCESS SOCIETY GUIDELINE SYNDROME AS A PREDOMINANTLY HYPERANDROGENIC SYNDROME: AN POSITION STATEMENT: CRITERIA FOR DEFINING POLYCYSTIC OVARY (2006) (6)
- Androgen-Insensitivity Syndrome: Long-Term Results of Surgical Vaginal Creation (1990) (5)
- Close correlation between hyperandrogenism and insulin resistance in women with polycystic ovary syndrome—Based on liquid chromatography with tandem mass spectrometry measurements (2018) (5)
- The predictive value of total testosterone alone for clinical hyperandrogenism in polycystic ovary syndrome. (2020) (5)
- Are patients with idiopathic hirsutism (IH) insulin resistant?: Comparing women with IH to body mass index-matched patients with polycystic ovary syndrome (PCOS) and controls (2004) (5)
- Pathogenesis of Hyperandrogenism in Polycystic Ovary Syndrome (2008) (5)
- What is the value and role of academic medicine in the life of its university? (2014) (5)
- Concordance of 21-hydroxylase gene ratio, human leukocyte antigen haplotyping and adrenal testing results in a family with late-onset adrenal hyperplasia. (1993) (5)
- Consensus on infertility treatment related to polycystic ovary syndrome (Human Reproduction (2007) 23, (462)) (2008) (5)
- Dexamethasone Receptor Levels in Palatal and Lung Fibroblasts of Adult A/J and C57BL/6J Mice: Relationship to Glucocorticoid-Induced Cleft Palate (1990) (5)
- The Effect of Diet and Exercise in Women with Polycystic Ovary Syndrome (2015) (5)
- Report on the Third Annual Meeting of the Androgen Excess Society, San Diego, California, June 3, 2005. (2006) (4)
- The Second International Symposium on the Developmental Aspects of Androgen Excess, Toronto, Canada, 20 June 2000 (2000) (4)
- Strategic Mergers in Higher Education (2019) (4)
- Reproducibility of the adrenal androgen response to adrenocorticotropic hormone stimulation. (2006) (4)
- Prevalence of insulin resistance in Polycystic Ovary Syndrome (PCOS) patients using the Homeostatic Measurement Assessment (HOMA-IR) (2003) (4)
- Genes for Enzymes Regulating DHEA Sulfonation are Associated with Levels of DHEA-Sulfate in Polycystic Ovary Syndrome 1 (2007) (4)
- Dexamethasone receptor levels in palatal and lung fibroblasts of adult A/J and C57BL/6J mice: relationship to glucocorticoid-induced cleft palate. (1990) (4)
- Perspectives: Like Waves in a Tarpit: Academia's Internal Communications Problem (2014) (4)
- Nonclassic adrenal hyperplasia. (1997) (3)
- An Update on Polycystic Ovary Syndrome (2007) (3)
- Screening for androgen excess in women: accuracy of self-reported excess body hair growth and menstrual dysfunction (2019) (3)
- How polycystic ovary syndrome came into its own. (2021) (3)
- Long-Term Morbidity of PCOS (2007) (3)
- PCOS Phenotype in Unselected Populations Study (P-PUP): Protocol for a Systematic Review and Defining PCOS Diagnostic Features with Pooled Individual Participant Data (2021) (3)
- O-26: The association of androgen levels with the severity of hirsutism in the polycystic ovary syndrome (PCOS) (2006) (3)
- Should employer-sponsored health insurance benefits be made public? (2002) (3)
- A faculty and resident development program to improve learning and teaching skills. (2009) (3)
- Association study of AMP-activated protein kinase subunit genes in polycystic ovary syndrome. (2009) (3)
- Profile of Daughters and Sisters of Women with Polycystic Ovary Syndrome: The Role of Proband's Glucose Tolerance. (2021) (3)
- Late onset adrenal hyperplasia: mutation at codon 282 of the functional 21-hydroxylase gene is not ubiquitous. (1990) (3)
- P-075 Idiopathic hirsutism (IH): An uncommon cause of hirsutism in Alabama (1997) (3)
- Comprehensive Evaluation of Disparities in Cardiometabolic and Reproductive Risk between Hispanic and White Women with Polycystic Ovary Syndrome in the United States: a Systematic Review and Meta-Analysis. (2021) (3)
- Demystifying fallacies surrounding nonclassic adrenal hyperplasia (1996) (3)
- Establishing Hemostasis at Laparoscopy (1992) (3)
- Hypothalamic-Pituitary-Adrenal Dysfunction in the Polycystic Ovary Syndrome (2006) (3)
- Authors’ Response: Troglitazone Use in Polycystic Ovary Syndrome (2001) (3)
- P-448 : Changes in the outpatient and inpatient utilization of female reproductive surgery, 1998-2002: Analysis of the Healthcare Cost and Utilization Project (2006) (2)
- Severe Insulin-Resistance Hyperandrogenic Syndromes (2006) (2)
- FEM 1 A and FEM 1 B : novel candidate genes for polycystic ovary syndrome (2008) (2)
- Definition and Epidemiology of the Polycystic Ovary Syndrome (2006) (2)
- Adrenocortical Dysfunction in the Polycystic Ovary Syndrome (1996) (2)
- Sexual function and polycystic ovary syndrome: a systematic review and meta-analysis (2016) (2)
- Alterations in plasma non-esterified fatty acid (NEFA) kinetics and relationship with insulin resistance in polycystic ovary syndrome (2019) (2)
- Fertility and infertility: Editorial overview (1992) (2)
- Practical Manual of Operative Laparoscopy and Hysteroscopy (1992) (2)
- POLYCYSTIC OVARY SYNDROME Dehydroepiandrosterone sulfate and insulin resistance in patients with polycystic ovary syndrome (2009) (2)
- Health System Creation and Integration at a Health Sciences University: A Five-Year Follow-up (2017) (2)
- Differential Diagnosis and Evaluation of Hyperandrogenism (2003) (2)
- The Nonclassic Adrenal Hyperplasias (2006) (2)
- Evaluation of infertility : A cost effective approach (1997) (2)
- Presidential and Academic Health Center Leadership within the Modern University: Opportunities and Challenges (2015) (2)
- Change in the diagnosis of patients with idiopathic hirsutism (IH) to Polycystic Ovary Syndrome (PCOS) due to the use of the 2003 Rotterdam criteria (2004) (2)
- AKT2 : First Evidence of Genetic Association with Polycystic Ovary Syndrome (2008) (2)
- History of Polycystic Ovary Syndrome, Premature Adrenarche, and Hyperandrogenism in Pediatric Endocrinology (2022) (2)
- delta 5-Androstene-3 beta,17 beta-diol in healthy eumenorrheic women: relationship to body mass and hormonal profile. (1994) (2)
- A Brief History of Androgen Excess (2006) (2)
- Training, certification, and credentialing in gynecologic operative endoscopy. (1995) (2)
- The Degree of Menstrual Disturbance Is Associated With the Severity of Insulin Resistance in PCOS (2021) (2)
- Amenorrhea, Oligomenorrhea, and Hyperandrogenic Disorders (2010) (1)
- Review Article Nonclassic Congenital Adrenal Hyperplasia (2010) (1)
- Women's Health: Advances in the evaluation and treatment of unwanted hair growth (2002) (1)
- Abnormal Expression of Genes Involved in Inflammation, Lipid Metabolism, and Wnt Signaling in the Adipose Tissue of Polycystic Ovary Syndrome (2012) (1)
- Letter to the editor re: Casarini and Brigante, 2014, from Azziz R., et al. (2015) (1)
- Adrenocortical dysfunction in androgen excess (1993) (1)
- Triglyceride to high-density lipoprotein cholesterol ratio as a predictor of insulin resistance in women with polycystic ovary syndrome (PCOS) (2011) (1)
- Effect of sex steroids and insulin on dehydroepiandrosterone sulfate production by hepatoma G2 cells. (2009) (1)
- Anti-mullerian Hormone Receptor Type II Gene Polymorphisms Similar Among Women With the Polycystic Ovary Syndrome (PCOS) and Controls (2009) (1)
- Obstetrics and Gynecology: Cases, Questions, and Answers (2006) (1)
- Value of 1-hour versus 2-hour insulin levels during the oral glucose tolerance test (OGTT) for identifying the degree of hyperinsulinemia (HI) in PCOS women (2010) (1)
- Laparoscopic Ovarian and Parovarian Surgery (1997) (1)
- POLYCYSTIC OVARY SYNDROME (PCOS): A DIAGNOSTIC CHALLENGE (2004) (1)
- O-078 Genotype and phenotype in women with 21-hydroxylase (21-OH) deficient non-classic adrenal hyperplasia (NCAH) (1997) (1)
- Pcos And Mendelian Randomization: Too Soon? (2021) (1)
- Adiposity in polycystic ovary syndrome: excess versus dysfunction. (2021) (1)
- [Infertility treatment before assisted reproductive techniques]. (2001) (1)
- Pregnancy-related economic burden of polycystic ovary syndrome (PCOS) (2019) (1)
- Abstract 4178: Cardiovascular Event-Free Survival in Post-Menopausal Women with Polycystic Ovary Syndrome: Results from the Women's Ischemia Syndrome Evaluation (2006) (1)
- Metabolic features of adult and adolescent first-degree relatives of women with polycystic ovary syndrome: a systematic review and meta-analysis (2017) (1)
- Clinical and Hormonal Evaluation of Androgen Excess (2006) (1)
- Where are we in understanding the natural history of polycystic ovary syndrome? A systematic review of longitudinal cohort studies (2022) (1)
- PostersReproductive Endocrinology (i.e. PCOS, Menarche, Menopause etc.) (2010) (1)
- The different phenotypes of the polycystic ovary syndrome (PCOS). (2001) (1)
- Women with polycystic ovary syndrome (PCOS) have lower basal metabolic rates compared to eumenorrheic controls (2013) (1)
- Hormonal and Metabolic Factors Influence the Action of Progesterone on the Endometrium of Women with Polycystic Ovary Syndrome (2023) (1)
- Differential binding of and testosterone to SHBG: Relation to circulating estradiol levels (1998) (1)
- The clinical management of Hirsutism: evidence based practice (2004) (1)
- Implementing a teaching service for voluntary faculty in obstetrics and gynecology: long-term results. (2013) (1)
- Why can’t a man be more like a mouse?: Reply of the authors (2001) (1)
- Reply: How many of the items in the polycystic ovary syndrome can be validated statistically? (2006) (1)
- Letter to the Editor: "Type B Insulin Resistance Masquerading as Ovarian Hyperthecosis". (2017) (1)
- Detection of CAH heterozygotes [5] (multiple letters) (1997) (1)
- Systemic chronic subclinical inflammation, adipose tissue dysfunction, and polycystic ovary syndrome: three major forces intertwined. (2021) (1)
- Publisher Correction: Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations (2020) (1)
- Obituary for John Benjamin Younger, Sr., M.D. (2003) (1)
- Giving Feedback (The Good and the Bad) (2009) (1)
- Laparoscopic Uterine Nerve Ablation, Presacral Neurectomy, and Appendectomy (1992) (1)
- Prevalence of adrenal androgen excess in patients with the polycystic ovary syndrome (PCOS) using age-specific DHEAS levels adjusted for body mass and ethnicity (2003) (1)
- Defining what is normal: the key to the diagnosis of polycystic ovary syndrome (and any other disorder for that matter…). (2019) (1)
- Photo and Video Documentation in Endoscopic Surgery (1997) (1)
- Erratum to: Impact of FTO genotypes on BMI and weight in polycystic ovary syndrome: a systematic review and meta-analysis (2012) (0)
- Atlas of Female Infertility Surgery, 2nd ed, R.B. Hunt. Mosby Yearbook Inc, Baltimore (MD) (1992), 1, Price $129.00 (1994) (0)
- Sexual function in polycystic ovary syndrome: a systematic review and meta-analysis (2016) (0)
- A Comparison of Insulin Action Between Women With 21-Hydroxy- lase-Deficient Nonclassic Adrenal Hyperplasia (NCAH) and Polycystic (2005) (0)
- EVALUATING OVARIAN VOLUME AS A SINGLE MARKER FOR POLYCYSTIC OVARY SYNDROME (PCOS) AND METABOLIC DYSFUNCTION (2020) (0)
- The severity of menstrual dysfunction serves as a predictor of insulin resistance in the polycystic ovary syndrome (PCOS) (2010) (0)
- P-869: Combination suppressive therapy in the polycystic ovary syndrome (PCOS): Predictors of success (2006) (0)
- Second international symposium on the developmental aspects of androgen excess disorders: Preface (2000) (0)
- The synergistic effects of co-culture on adiponectin secretion in polycystic ovary syndrome (2008) (0)
- The Hispanic patient. (1981) (0)
- Endocrine Society MTP Diagnosis and Management of Androgen Excess (2015) (0)
- Adenomyosis, Leiomyomata, and Pelvic Pain (1998) (0)
- Visually quantifying normal and abnormal hair growth in women (2009) (0)
- Co-culture of adipocytes and resident macrophages affects monocyte chemoattractant protein-1 secretion in polycystic ovary syndrome (2007) (0)
- PMON247 Prevalence of Polycystic Ovary Syndrome in Eastern Siberia: a Cross-Sectional Study. (2022) (0)
- Publisher Correction: Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations (2020) (0)
- 3β-Hydroxysteroid Dehydrogenase Deficient NCAH: A Myth or Reality? (2006) (0)
- Black Women Have a Worse Cardio-Metabolic Risk Profile Compared to White Women with Polycystic Ovary Syndrome in the United States: A Systematic Review and Meta-Analysis (2021) (0)
- Reply of the Authors: Criteria for the polycystic ovary syndrome (2009) (0)
- Polycystic Ovary Syndrome: Adrenocortical dysfunction in polycystic ovary syndrome (2007) (0)
- Adrenal androgens in the polycystic ovary syndrome (2002) (0)
- Use of fasting blood glucose levels to detect the presence of glucose intolerance in polycystic ovary syndrome (PCOS) (2010) (0)
- Replication of Genetic Variants for Polycystic Ovary Syndrome (PCOS) In a European Cohort (2014) (0)
- The glucose to insulin ratio (GIR) is useful predicting insulin resistance (IR) only in obese, but not non‐obese, women with hyperandrogenism (HA) (2000) (0)
- Exploring the relationship between PCOS and Type 2 diabetes mellitus (2002) (0)
- Abstract 5025: Transition to Menopause and Preclinical Atherosclerosis in Women: A Report from the Los Angeles Atherosclerosis Study (LAAS) (2008) (0)
- Berberine regulates the protein expression of multiple tumorigenesis-related genes in hepatocellular carcinoma cell lines (2017) (0)
- Acute myometritis and chorioamnionitis during cesarean section of asymptomatic women (1989) (0)
- 423 GENETIC VARIATION IN 5α-REDUCTASE INFLUENCES DEVELOPMENT OF POLYCYSTIC OVARY SYNDROME AND SEVERITY OF HIRSUTISM. (2006) (0)
- Artist’s Statement: Paranoia (2014) (0)
- PCOS and normal menses: Another point of view (2003) (0)
- Editor's formulation - The late-onset adrenal hyperplasias: An example of molecular biology applied to the study of androgen excess disorders (1993) (0)
- DIFFERENCES IN PCOS PRESENTATION AMONG BLACK WOMEN IN CALIFORNIA AND ALABAMA (2020) (0)
- PMON244 Alterations in Nonesterified Free Fatty Acids (NEFA) Trafficking Rather Than Hyperandrogenism Contribute to Variations in Insulin Sensitivity Among Obese Women with Polycystic Ovary Syndrome (2022) (0)
- Comprar Obstetrics & Gynecology | Ricardo Azziz | 9780071458207 | Mcgraw-Hill Education (2007) (0)
- Is hirsutism a marker of metabolic dysfunction? (2019) (0)
- Racial and Ethnic Disparities in Polycystic Ovary Syndrome. (2023) (0)
- Abstract 5027: Endogenous and Exogenous Reproductive Hormones and Preclinical Atherosclerosis in Women: The Los Angeles Atherosclerosis Study (LAAS) (2008) (0)
- Technology Transfer and Commercialization as a Source for New Revenue Generation for Higher Education Institutions and for Local Economies (2021) (0)
- use and metabolic side effects expression: clues to the association between valproate Valproate-induced alterations in human theca cell gene (2015) (0)
- The Need to Reassess the Diagnosis of Polycystic Ovary Syndrome (PCOS): A Review of Diagnostic Recommendations from the International Evidence-Based Guideline for the Assessment and Management of PCOS (2021) (0)
- Heritability of dehydroepiandrosterone sulfate in women with polycystic ovary syndrome and their sisters (2007) (0)
- Goodarzi MO, Jones MR, Chen Y-DI, Azziz R. First evidence of genetic association between AKT2 and polycystic ovary syndrome. Diabetes Care 2008;31:2284-2287 (2009) (0)
- Physiology and pathology of adrenal disorders (2002) (0)
- Metformin use in polycystic ovary syndrome: metabolic benefits and diabetes prevention. (2008) (0)
- New name, school still addressing physician shortages in Georgia. (2011) (0)
- Facial hair growth in hirsuite women with polycystic ovary syndrome (PCOS) correlates with hyperinsulinemia (2008) (0)
- RF10 | PMON218 Direct Costs of Mental Health Disorders in PCOS: Systematic Review and Meta-Analysis (2022) (0)
- The polycystic ovary syndrome: the first 150 years of study (2022) (0)
- Direct Economic Burden of Mental Health Disorders Associated with Polycystic Ovary Syndrome: Systematic Review and Meta-analysis (2023) (0)
- A Comparison of Insulin Action Between Women With 21-Hydroxylase-Deficient Nonclassic Adrenal Hyperplasia (NCAH) and Polycystic Ovary Syndrome (PCOS) (2005) (0)
- Body fat distribution and lean body mass (by CT scan) as a determinant of insulin resistence by FSIVGTT in polycystic ovary syndrome (2010) (0)
- Cover Story/CME: Evaluation and treatment of unwanted hair growth (2002) (0)
- Editor's formulation: Towards a working classification of androgen excess disorders (1994) (0)
- Troglitazone use in polycystic ovary syndrome [letter] [reply] (2001) (0)
- and polycystic ovary syndrome?: a systematic review and meta-analysis (2012) (0)
- P-870 : Dehydroepiandrosterone sulfate (DHEAS) as a predictor of insulin resistance in patients with polycystic ovary syndrome (PCOS) (2006) (0)
- The phenotype of polycystic ovary syndrome (PCOS) in Hispanic vs. non-Hispanic White women (2010) (0)
- Sensitivity and responsiveness to ACTH of adrenal secretion of Dehydrocpiandrosterone (DHEA) and cortisol in aging women (1998) (0)
- Relationship of ovarian morphology to degree of menstrual cycle dysfunction and insulin resistance in polycystic ovary syndrome (PCOS) (2010) (0)
- Family size in the Polycystic Ovary Syndrome (PCOS) (2004) (0)
- Is antimüllerian hormone an early marker or an in utero effector of incipient polycystic ovary syndrome? (2019) (0)
- Puberty and Disorders of Pubertal development (2010) (0)
- Detection of CAH heterozygotes. (1997) (0)
- Reply of the Authors: Dehydroepiandrosterone sulfate and insulin resistance in patients with polycystic ovary syndrome (2009) (0)
- Increased total and phosphorylated glycogen synthase kinase-3 (GSK-3) in the adipocytes of patients with the polycystic ovary syndrome (PCOS) (2004) (0)
- "Letter to the Editor: Distribution of Body Hair in Young Australian Women and Associations with Serum Androgen Concentrations". (2020) (0)
- Comprar Androgen Excess Disorders in Women | Azziz, Ricardo | 9781588296634 | Springer (2007) (0)
- Polycystic ovary syndrome, microbiomics and why you should be a little selfish with your time (2013) (0)
- PMON245 Clinical Phenotypes of Polycystic Ovary Syndrome (PCOS) in Nigerian Women: Preliminary Results of the Nigeria PCOS Epidemiology & Phenotype (Nigeria-Pep) Study (2022) (0)
- Inconclusive results from the study evaluating the use of blunt needles during obstetric laceration repair (2009) (0)
- P-868: Prevalence of hyperandrogenemia in the polycystic ovary syndrome (2006) (0)
- Comprar Obstetrics & Gynecology | Ricardo Azziz | 9780071100052 | Mcgraw-Hill Education (2007) (0)
- JAMA Peer Reviewers for 2003 (2017) (0)
- Endocrinology of the Ovary (2005) (0)
- BRIEF REPORT The Age-Associated Decline of Androgens in Reproductive Age and Menopausal Black and White Women (2007) (0)
- When is late-onset adrenal hyperplasia not late-onset adrenal hyperplasia? (1991) (0)
- Establishing Normative Values to Determine the Prevalence of Biochemical Hyperandrogenism in Premenopausal Women of Different Ethnicities from Eastern Siberia (2022) (0)
- Reproducibility of adrenal androgen levels and their response to the adrenocorticotropic hormone (ACTH) stimulation test (2004) (0)
- Financial fluency: demystifying accounting and business planning for the reproductive medicine specialist. (2020) (0)
- Variants in genes involved in androgen signaling as genetic determinants of polycystic ovary syndrome (PCOS) (2010) (0)
- Regional Variation in Hormonal and Metabolic Parameters of White and Black Women With PCOS in the United States. (2022) (0)
- Electrosurgery and Thermocoagulation at Operative Endoscopy (1997) (0)
- Abstract 3649: Menstrual Cycling and Mechanisms of Cardiovascular Disease Events in Post-Menopausal Women: Results from the NIH-NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) (2007) (0)
- Ovarian volume as an independent marker for metabolic dysfunction in women with suspected androgen excess (2022) (0)
- PMON248 Predictive value of markers of hyperandrogenism in 1610 women with PCOS (2022) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Ricardo Azziz?
Ricardo Azziz is affiliated with the following schools: